GlobalPost reports on the GBCHealth Conference, which took place in New York City on Monday and where “panelists at a session titled ‘AIDS@30’ were asked how they would fulfill U.S. Secretary of State Hillary Clinton’s call late last year for an ‘AIDS-free generation.'” According to the news service, “Ambassador Eric Goosby, the U.S. global AIDS coordinator, said the key will likely be a combination HIV prevention strategy” that “includes expansion of treatment to help prevent new infections; major scale-up of male circumcision; and treating all HIV-positive pregnant women to end the transmission of HIV from mother to child.” GlobalPost adds, “Michel Sidibe, UNAIDS executive director, said the way to defeat AIDS had to include more financial contributions from developing countries.” GlobalPost quotes several other conference attendees (Donnelly, 5/15).
Private Sector Involvement
“The worldwide counterfeit drug market is huge and growing,” Tim Mackey and Brian Liang of the Institute of Health Law Studies at the California Western School of Law and Thomas Kubic of the Pharmaceutical Security Institute write in a Foreign Policy opinion piece, noting such “drugs occupy a wide spectrum of medications, and their quality is suspect; they can be mislabeled, tainted, adulterated, ineffective, or, in the worst cases, all of the above.” They argue for a new framework for fighting the illegal drug trade because “[g]lobal policy has not kept up with the burgeoning counterfeit drug trade.” The authors say that although initial results of the WHO IMPACT (International Medical Products Anti-Counterfeit Taskforce) are “encouraging,” they note that “[s]ome WHO member states, including India and Brazil (both top producers of generic drugs) and other developing countries, have questioned whether WHO can rightly take on enforcement operations” because it “is not a global law enforcement agency.”
The National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) announced a pilot program under which “three pharmaceutical companies have agreed to make dozens of their failed compounds available to researchers, who will investigate if the compounds can be re-purposed into successful treatments for other diseases,” Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC), writes in the group’s “Breakthroughs” blog. “With this new therapeutics program, NIH and NCATS have created an exciting, innovative model for collaboration between the public and private sectors. … Now NCATS must ensure that research for neglected diseases is encouraged and supported through this initiative,” Bennett says (5/7).
In a “wide-ranging,” two-part interview with AllAfrica.com, Unni Karunakara, the international president of Medecins Sans Frontieres (MSF), “spoke about the values that underpin the work of MSF, the organization’s culture and its passion for principled humanitarian action,” the news service writes. “Humanitarian aid has come a long way in the last 40 years, says … Karunakara, but he warns that important health care gains made in the last decade may be reversed if funding is not maintained,” the news service notes. In part one of the interview, Karunakara discusses “gains made in reducing medicine costs and providing treatment for AIDS, tuberculosis and malaria,” as well as “the challenges MSF faces in remaining independent and principled in conflict situations.” In part two of the interview, “he looks at the future of MSF in a changing world” (Valentine, 5/7).
The Center for Global Health Policy’s “Science Speaks” blog notes that PEPFAR recently released its 8th annual report (.pdf) to Congress. “The five-page document outlines the program’s progress as of the end of fiscal year 2011 in various areas,” including the provision of antiretroviral treatment, care, and support; HIV testing and counseling for pregnant women; and prevention of mother-to-child transmission services, the blog notes. The report includes sections on “leading with science,” “smart investments,” “country ownership,” and “shared responsibility,” according to the blog (Mazzotta, 5/4).
Ghana’s recent “rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, [makes it] the first country in sub-Saharan African to introduce two new vaccines at the same time,” the Guardian reports. The immunization campaign, organized by the Ghanaian government and the GAVI Alliance in partnership with other international agencies, philanthropies and the private sector, is “expected to save thousands of lives,” the newspaper notes. “That GAVI has deemed Ghana able to introduce rotavirus and pneumococcal vaccines together is a vote of confidence in the country’s ability to establish a ‘cold chain,'” a refrigeration network necessary to keep the vaccines viable, according to the Guardian.
In a post on USAID’s “IMPACTblog,” Amanda Makulec of John Snow Inc. describes the Helping Babies Breathe (HBB) initiative, which was developed “to equip birth attendants in developing countries with the skills they need to successfully resuscitate babies born without the ability to breathe on their own.” She continues, “[I]t was the power of the Global Development Alliance (GDA) model — public-private partnership on a global scale — that dramatically expanded access to newborn resuscitation in remote health facilities and communities in 34 countries within 18 months of the launch of the partnership … by leveraging the commitment, resources, and support of a diverse group of program implementers, NGOs, private sector organizations, government institutions, U.N. agencies, professional associations to enable the rapid roll out of the intervention globally” (4/30).
U.K. International Development Secretary Andrew Mitchell on Friday “announced a doubling of the U.K.’s effort to provide clean water and sanitation to the world’s poorest countries,” the Guardian reports (Elliot, 4/20). At a High-Level Meeting on Water and Sanitation in Washington, D.C., Mitchell “announced that the U.K., through [the Department for International Development (DfID)], would double the number of people it reached with aid in water, sanitation and hygiene education in the next two years, going from 30 to 60 million people globally by 2015,” according to a UNICEF press release (4/20).
Strategic Innovations Will Help Prevent HIV Transmission From Mothers To Children, High-Level Meeting Attendees State
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., “HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries — home to 90 percent of new HIV infections among children –” agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports. “The priority countries are Angola, Botswana, Burundi, Cameroon, Chad, Cote d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe,” the news service notes.
This post on IntraHealth International’s “Global Health Blog” discusses a new report (.pdf) from the WHO, titled “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination,” which “concludes that ‘all countries should commit to spend at least 0.01 percent of GDP on government-funded R&D [research and development] devoted to meeting the health needs of developing countries.'” The post states, “The report has a double significance. First, it is a vigorous statement of the need for a binding agreement on health innovation to address diseases that mostly affect developing countries. Second, it is an important concrete step on the long path to it” (Chiscop, 4/13).